Latest / Green Bay News Today | 2 Min News | The Daily News Now!
New Pill Offers Hope for Pancreatic Cancer | Green Bay News
Pancreatic cancer just got a major breakthrough: the FDA approved Rasonque, a pill that targets the elusive KRAS protein fueling aggressive cancers. In trials, patients lived an average of 13 months—doubling survival compared to chemo’s 7 months. Side effects include nausea and fatigue, but the price? Likely hundreds of thousands annually. This targeted therapy marks a huge leap forward in the fight against one of medicine’s toughest foes. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.